Schug B S, Kalbhen D A
Zentrallaboratorium Deutscher Apotheker, Eschborn, Germany.
Arzneimittelforschung. 1995 Mar;45(3):285-9.
To investigate the influence of certain drugs and agents upon collagenolytic activity in human cartilage, homogenized articular cartilage from osteoarthritic human hips was incubated with dexamethasone, diclofenac, indometacin, phenazone, phenylbutazone, tiaprofenic acid, sulfasalazine, penicillamine, chloroquine, cysteine and a glycosaminoglycan-peptide complex (DAK-16). Collagenolytic activity was quantitated by the release of soluble hydroxyproline-containing peptides. The presence of collagenase in osteoarthritic cartilage was proved by the typical 75:25 cleavage products of type I collagen. Enzymatic collagen breakdown was found to be inhibited by chloroquine, cysteine, DAK-16, and sulfasalazine whereas the other tested agents had no significant effect. The inhibitory potency of chloroquine at therapeutical dose levels may be of pharmacological and therapeutic relevance.
为研究某些药物和制剂对人软骨中胶原酶活性的影响,将取自骨关节炎患者髋关节的关节软骨匀浆与地塞米松、双氯芬酸、吲哚美辛、非那宗、保泰松、噻洛芬酸、柳氮磺胺吡啶、青霉胺、氯喹、半胱氨酸以及一种糖胺聚糖 - 肽复合物(DAK - 16)一起孵育。通过含可溶性羟脯氨酸肽的释放来定量胶原酶活性。骨关节炎软骨中胶原酶的存在通过I型胶原典型的75:25裂解产物得以证实。发现氯喹、半胱氨酸、DAK - 16和柳氮磺胺吡啶可抑制酶促性胶原降解,而其他受试制剂无显著作用。治疗剂量水平的氯喹的抑制效力可能具有药理学和治疗学意义。